UMU logo

Nordic collaboration received project grant for Research within post-COVID syndrome 2021 from the Swedish Research Council

Text written by Nóra Lehotai

The Swedish Research Council (Vetenskapsrådet) has awarded 14 projects for Research within post-COVID syndrome 2021, with a total amount of 50 mio SEK. One of the funded projects was submitted by Dr. Anne-Marie Fors Connolly, MIMS clinical research fellow, researcher at the Department of Clinical Microbiology (Umeå University) and clinician at the University Hospital of Umeå.

“This project is a collaboration with Dr. Andrea Ganna (FIMM-EMBL), Dr. Hanna Ollila (FIMM-EMBL), Prof. Naja Hulvej Rod (Copenhagen University) and Dr. Elin Thysell (Umeå University)”, says Anne-Marie.

 

Colored virus line all

Picture: Corona virus under electron microscope. Credit: Linda Sandblad, UCEM.


The aim of this project is to determine clinical features and organ impact of post-COVID syndrome by creating a Nordic database combining Swedish, Finnish and Danish Registry Data for all individuals diagnosed with SARS-CoV-2 infection. The information the researchers get from the combined registry inputs will provide longitudinal and prospective data for more than 1.5 million COVID-19 patients. This will enable them to authoritatively characterize post-COVID syndrome and identify both common and rare symptomatology of post-COVID syndrome.


Anne Marie Fors ConnollyAnne-Marie concludes: “I am delighted to have received this grant, because it will enable this project that combines data from three Nordic countries to characterize the symptomatology and also risk factors such as age, sex, socioeconomic, demographic and comorbidity, for post-COVID-19 syndrome. Using biobank samples, we also hope to identify biomarkers that could potentially predict which individuals are at risk of post-COVID-19 syndrome. “

Picture: Anne-Marie Fors Connlly, key investigator of the scientific project. Credit: Mattias Petterson. 


Two of the collaborative partners, Dr. Andrea Ganna and Dr. Hanna Ollila, are from the Institute for Molecular Medicine Finland (FIMM), one of the nodes in the Nordic EMBL Partnership for Molecular Medicine. The Nordic EMBL Partnership combines a Danish (DANDRITE), Finnish (FIMM), Norwegian (NCMM) and Swedish (MIMS) research center with excellent knowledge and training within infection biology and medicine to strengthen scientific collaboration and knowledge trade among the Nordic countries.

“This is a great example of a collaboration born within the Nordic EMBL Partnership, which really highlights the strengths of Nordic countries in registry-based and biobank research” says Andrea from FIMM.

 

Original project title:
In English: Mapping and risk factor analysis of post-covid in a Nordic database and biobank data.
In Swedish: Kartläggning och risk faktoranalys av post-covid i en Nordisk databas och biobanksdata.

Members of the project:
Prof. Naja Hulvej Rod, Department of Public Health, Section of Epidemiology, University of Copenhagen
Dr. Elin Thysell, Department of Medical Biosciences, Umeå University
Dr. Andrea Ganna, Institute for Molecular Medicine Finland (FIMM), Data science genetic epidemiology lab
Dr. Hanna Ollila, Institute for Molecular Medicine Finland (FIMM), Genetics of sleep, circadian rhythms and brain autoimmunity lab
Dr. Anne-Marie Fors Connolly, MIMS clinical research fellow, researcher at the Department of Clinical Microbiology (Umeå University), clinician at the University Hospital of Umeå

 

See the statistics from the Swedish Research Council regarding Research within post-COVID syndrome 2021: https://www.vr.se/english/applying-for-funding/decisions/2021-08-25-project-grant-for-research-within-post-covid-syndrome.html

Visit the website of Nordic EMBL Partnership for Molecular Medicine for more information: https://projects.au.dk/nordic-embl-partnership/

 

Contact:

Anne-Marie Fors Connolly, leader of the scientific project

This email address is being protected from spambots. You need JavaScript enabled to view it.

Nóra Lehotai, project coordinator and responsible for communications at MIMS

This email address is being protected from spambots. You need JavaScript enabled to view it.

Emmanuelle Charpentier took the Nobel Prize in Chemistry

Emmanuelle has been awarded jointly with Jennifer Doudna the 2020 Nobel Prize in Chemistry for discovering the groundbreaking CRISPR-Cas9 gene editing technology. She is a former group leader at MIMS, honorary doctor at Umeå University and former visiting professor at UCMR.

Movie by Knut and Alice Wallenberg Foundation (https://kaw.wallenberg.org/)

Battling antibiotic resistance

movie by Knut and Alice Wallenberg Foundation, with participation of scientists from MIMS and UCMR:
Or watch the original movie on:
https://kaw.wallenberg.org/

Research about infectious diseases:

Oliver Billker in movie of Knut and Alice Wallenberg Foundation:
Or watch the original movie on:
https://kaw.wallenberg.org/

footer all slides 2014-02-06


Copyright © 2019 by The Laboratory for Molecular Infection Medicine Sweden (MIMS). All rights reserved.